潜在的临床试验,以推进免疫检查点抑制剂毒性的研究

Christopher Cluxton1,2, Jarushka Naidoo1,2,3

  • 1Beaumont Hospital, RCSI Cancer Centre, D09 V2N0 Dublin, Ireland.

概括

免疫检查点抑制剂 (ICI) 提供持久的抗瘤反应,但会增加与免疫相关的不良事件 (IRAE). 本审查审查了临床试验,以建立基于证据的指导方针来管理ICI毒性.

相关概念视频

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.9K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K